文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19危重症患者的肺部微生物群与非缓解性急性呼吸窘迫综合征相关

Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01
一句话结论在机械通气的COVID-19相关ARDS患者中,肺部细菌和真菌负荷越高,60天成功拔管可能性越低、死亡率越高。

该观察性队列研究纳入114例机械通气的COVID-19相关ARDS患者,经支气管镜肺泡灌洗采样,用16S rRNA基因测序和定量PCR(靶向16S和18S rRNA基因)分析肺部微生物群。主要终点为插管后60天成功拔管(以死亡为竞争风险)。细菌负荷每增加1个log10,成功拔管的亚分布风险比为0.64(95%CI 0.42-0.97;P=0.034);真菌负荷每增加1个log10,亚分布风险比为0.59(95%CI 0.42-0.83;P=0.0027);细菌负荷与死亡率相关(P=0.012),真菌负荷与死亡率相关(P=0.0498)。肺部微生物群组成与成功拔管相关(P=0.0045);促炎细胞因子(如肿瘤坏死因子-α)与微生物负荷相关。

要点

  • 细菌负荷每增加1个log10,60天成功拔管的亚分布风险比为0.64(95%CI 0.42-0.97;P=0.034)。
  • 真菌负荷每增加1个log10,60天成功拔管的亚分布风险比为0.59(95%CI 0.42-0.83;P=0.0027)。
  • 细菌负荷与死亡率相关(P=0.012),真菌负荷与死亡率相关(P=0.0498)。
  • 肺部微生物群组成与成功拔管相关(P=0.0045)。
  • 促炎细胞因子(如肿瘤坏死因子-α)与微生物负荷相关。

适用人群与场景

  • 机械通气的COVID-19患者,均符合ARDS并接受支气管镜肺泡灌洗。

研究设计与关键结果

  • 观察性队列研究,纳入114例独特COVID-19患者的肺泡灌洗样本,分析肺部微生物群(细菌和真菌负荷、α多样性、群落组成)与临床结局的关系。
  • 主要终点为插管后60天成功拔管,采用竞争风险回归模型(死亡为竞争风险)。
  • 细菌负荷每增加1个log10,成功拔管的亚分布风险比为0.64(95%CI 0.42-0.97;P=0.034);真菌负荷每增加1个log10,亚分布风险比为0.59(95%CI 0.42-0.83;P=0.0027)。
  • 细菌负荷与死亡率相关(P=0.012),真菌负荷与死亡率相关(P=0.0498)。
  • 肺部微生物群组成与成功拔管相关(P=0.0045)。
  • 促炎细胞因子(如肿瘤坏死因子-α)与微生物负荷相关。

证据类型、等级与局限

  • 证据类型:观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,细菌和真菌肺部微生物群与COVID-19中非缓解性ARDS相关,并代表COVID-19相关ARDS异质性的重要 contributor。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Bacterial lung microbiota are correlated with lung inflammation and acute respiratory distress syndrome (ARDS) and altered in severe coronavirus disease (COVID-19). However, the association between lung microbiota (including fungi) and resolution of ARDS in COVID-19 remains unclear. We hypothesized that increased lung bacterial and fungal burdens are related to nonresolving ARDS and mortality in COVID-19. Objectives: To determine the relation between lung microbiota and clinical outcomes of COVID-19-related ARDS. Methods: This observational cohort study enrolled mechanically ventilated patients with COVID-19. All patients had ARDS and underwent bronchoscopy with BAL. Lung microbiota were profiled using 16S rRNA gene sequencing and quantitative PCR targeting the 16S and 18S rRNA genes. Key features of lung microbiota (bacterial and fungal burden, α-diversity, and community composition) served as predictors. Our primary outcome was successful extubation adjudicated 60 days after intubation, analyzed using a competing risk regression model with mortality as competing risk. Measurements and Main Results: BAL samples of 114 unique patients with COVID-19 were analyzed. Patients with increased lung bacterial and fungal burden were less likely to be extubated (subdistribution hazard ratio, 0.64 [95% confidence interval, 0.42-0.97]; P = 0.034 and 0.59 [95% confidence interval, 0.42-0.83]; P = 0.0027 per log10 increase in bacterial and fungal burden, respectively) and had higher mortality (bacterial burden, P = 0.012; fungal burden, P = 0.0498). Lung microbiota composition was associated with successful extubation (P = 0.0045). Proinflammatory cytokines (e.g., tumor necrosis factor-α) were associated with the microbial burdens. Conclusions: Bacterial and fungal lung microbiota are related to nonresolving ARDS in COVID-19 and represent an important contributor to heterogeneity in COVID-19-related ARDS.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kullberg RFJ, de Brabander J, Boers LS, et al. Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022. PMID: 35616585. doi:10.1164/rccm.202202-0274OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。